Pandemic Influenza (H1N1) and Mycobacterium tuberculosis Co-infection
Yehyun Park1, Bum Sik Chin1, Sang Hoon Han1
1Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Abstract:
We hereby observe four co-infection cases of pandemic influenza H1N1 and Mycobacterium tuberculosis with various clinical presentations. It may be prudent to consider M. tuberculosis co-infections when patients with pandemic influenza reveal unusual clinical features that do not improve despite appropriate treatments against the influenza, especially in Korea, in the endemic areas of M. tuberculosis.
Insights
This study reports four cases of co-infection with pandemic influenza H1N1 and Mycobacterium tuberculosis. Consider tuberculosis in influenza patients with persistent, unusual symptoms, particularly in endemic regions like Korea.
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Background:
- Pandemic influenza H1N1 poses a significant global health threat.
- Mycobacterium tuberculosis (M. tuberculosis) remains a leading cause of infectious disease mortality worldwide.
- Co-infections can complicate disease presentation and treatment.
Purpose of the Study:
- To report on co-infection cases of pandemic influenza H1N1 and M. tuberculosis.
- To highlight the importance of considering M. tuberculosis in influenza patients with atypical presentations.
Main Methods:
- Case series observation.
- Clinical data review of four patients presenting with influenza-like illness.
Main Results:
- Four cases of concurrent pandemic influenza H1N1 and M. tuberculosis infection were identified.
- Patients exhibited diverse and unusual clinical features.
- Standard influenza treatment did not resolve symptoms in these co-infected individuals.
Conclusions:
- Co-infection with M. tuberculosis should be suspected in pandemic influenza patients presenting with non-resolving or atypical symptoms.
- Early consideration of M. tuberculosis is crucial for appropriate diagnosis and management, especially in endemic areas.
- Geographic location (e.g., Korea) and endemicity of M. tuberculosis are important factors in clinical suspicion.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:27Influenza